49:47
Addressing Purification Challenges for Complex Therapeutics with Custom Chromatography Resins
33:33
Shaken, Not Stirred Rocking Motion Versus Impeller Technology and What is Optimal
20:23
Grow Your CDMO With the Addition of Gloveless, Robotic Aseptic Filling
36:01
Flexible and Customized Approach to Lentiviral Vector Development and Manufacture
17:55
Product Quality in Focus
33:48
Streamline cGMP Viral Vector Analytical Challenges With Robust and Sensitive Impurity
22:33
WuXi Advanced Therapies Virology Operations: Cell & Gene Therapy Vector Regulatory Testing
22:30
High Performance With GMP Ready CHT Prepacked Process Scale Columns
27:14
Viral Clearance: A WuXi Advanced Therapies Perspective
45:21
Stability Assessment of mRNA Formulations – Toward the Development of Degradation Assays for mRNA
21:55
Leveraging NISTmAb Prior Knowledge to Demonstrate Analytical Competency
18:43
Next Generation PATfixTM Software
20:05
Screen Smarter Not Harder Expand and Accelerate Your Cell Line & Viral Vector Screening
30:24
Robust Methods for Stability and Identity Testing of Cell and Gene Therapies
31:15
Improve Your Cell Line Development Workflows with Analytical Tools
26:22
Enabling mRNA Based Therapeutics Development Through Efficient and Scalable mRNA Purification Method
28:28
Increasing Productivity of IVT Reaction Using At Line Monitoring by HPLC Chromatography
16:10
Streamlined AAV Manufacture From Plasmid Design to GMP Production
19:30
Small Format Connections for Optimizing Manufacturing
19:39
Less is More in mRNA Therapeutics Developing Big Ideas in Small Scale
10:37
Ensuring Leak Free Performance During Tissue Container Shipping Utilizing ASTM D4991
23:52
Robust and Scalable MAb Capture Facilitated by a Novel Convecdiff Membrane Structure
36:50
Sustaining Project Management Business Continuity and Partnerships Throughout COVID
18:15
The Critical Role of Cell Culture Media Analysis in Cell and Gene Therapies Development
24:14
Minimize Risk With Rapid At Line Concentration Measurement in Downstream Bioprocessing Applications
32:00
Moving Beyond PEI Improved Transfection Processes for AAV and LV Manufacture
13:06
Promoter Discovery for Optimized Viral Vector Development
35:06
Improving Gene Therapy Viral Vector Manufacturing Economics Modelling Bioprocess Costs
10:54
Ending CO2 Transmission Problems Using Purillex® Containers
19:12
Purification of DNA Oligonucleotides Using Anion Exchange Chromatography
20:10
Bioprocess Considerations for Large Scale Transfection
20:36
Best Practices in Mycoplasma Testing for Cell and Gene Therapies
29:44
Benefits of Hollow Fiber Filter Cell Expansion
19:55
Analytical Tools to Improve Production of Full Capsids in Initial Stages of AAV Process Development
49:47
Addressing Purification Challenges for Complex Therapeutics with Custom Chromatography Resins
20:01
A Flexible Intensified Seed Train to Boost Biopharma Productivity
23:44
Drug Discovery Screening Approaches for Rapid Assessment of Target Tractability
17:14
Downstream Process Development for the Purification of Biosimilar Insulin from Escherichia Coli
21:29
Development of LentiVEX™ Packaging and Producer Cell Lines for Lentivirus Manufacture
01:10:58
Developing Methods for Comparability Studies of Therapeutic Monoclonal Antibodies
12:29
Developing a Platform for Large Scale Lentiviral Manufacture
18:29
Continuity of Methods: Characterizing Protein Therapeutic Stability From Developability Assessment
35:48
Comprehensive Virus Clearance Evaluation Using Micro Scale Membrane Adsorbers
22:36
Bridging Anti CHO HCP Antibodies From Two Third Generation Cygnus CHO HCP ELISA Kits by AAE MS™
27:13
Accelerate Biologic Process Development and GMP Manufacturing
12:27
Improving Plasmid Design, Process and Manufacturing to Improve Viral Vector Yield
24:23
Manufacturing Capacity and Supply Chain Resilience
18:37
Scaling and Stirring: Success Factors in Scale Up with Single Use Benchtop Bioreactors
49:29
Cell Media Analysis: A Critical Piece of the Bioprocessing Puzzle
31:48
Efficient and Scalable GMP Manufacture of AAV and LV with TransIT VirusGEN® Reagent and Enhancers
20:21
Optimized Expression Systems for Increased Productivity in CHO DG44 Based Cell Line Development
13:56
Container Closure Integrity Testing of Bottles Used for Cell Therapy Applications
11:33
Analytical Ultracentrifugation for Profiling AAV Gene Therapies Where Are We Now?
16:40
Optimization of an Anion Exchange Method for the Large Scale Production of Plasmid DNA
18:03
Adenovirus Vector Manufacturing Platform Using CIMmultus QA
56:25
Practical Approaches to Metals Analysis of Cell Culture Media
48:34
Modernize Your Gene Therapy Analytics with Automated Tools from Bio Techne
34:29
Development of an Automated AAV8 Capsid Titer Assay on Gyrolab® xPand Immunoassay Platform
41:39
BioProcess Insider State of the Industry | December 2021 Panel Discussion
21:43
Scalable Lentiviral Vector Manufacturing Using Proprietary Suspension Cell Line
X
About
Tags